Total Payments
$9,229
2024 Payments
$5,063
Companies
27
Transactions
380
Medicare Patients
4,191
Medicare Billing
$209,691
Payment Breakdown by Category
Food & Beverage$8,592 (93.1%)
Education$636.95 (6.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,592 | 373 | 93.1% |
| Education | $636.95 | 7 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,774 | 93 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,539 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $1,118 | 49 | $0 (2024) |
| Dermavant Sciences, Inc. | $889.97 | 36 | $0 (2024) |
| GENZYME CORPORATION | $463.92 | 15 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $429.62 | 19 | $0 (2024) |
| LEO Pharma Inc. | $415.15 | 14 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $383.50 | 12 | $0 (2024) |
| Incyte Corporation | $331.38 | 8 | $0 (2024) |
| Amgen Inc. | $298.29 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,063 | 207 | E.R. Squibb & Sons, L.L.C. ($907.01) |
| 2023 | $3,161 | 122 | ABBVIE INC. ($735.12) |
| 2022 | $837.72 | 43 | ABBVIE INC. ($300.58) |
| 2021 | $166.80 | 8 | Lilly USA, LLC ($77.76) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $110.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.49 | General |
| Category: Immunology | ||||||
| 12/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: ANTIBIOTIC | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.25 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Immunology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.35 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: ANTIBIOTIC | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $123.10 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,788 | 2,671 | $626,870 | $88,731 |
| 2022 | 16 | 1,550 | 2,357 | $480,641 | $80,003 |
| 2021 | 9 | 853 | 1,363 | $239,467 | $40,957 |
Total Patients
4,191
Total Services
6,391
Medicare Billing
$209,691
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 387 | 475 | $124,925 | $23,392 | 18.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 191 | 222 | $93,018 | $13,305 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 205 | 205 | $65,805 | $12,115 | 18.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 198 | 213 | $80,514 | $11,459 | 14.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 281 | 350 | $106,271 | $10,361 | 9.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 152 | 175 | $25,818 | $5,197 | 20.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 172 | 788 | $66,192 | $2,949 | 4.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 76 | 76 | $16,983 | $2,824 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 32 | $11,904 | $2,290 | 19.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 50 | 77 | $15,785 | $2,170 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,636 | $1,174 | 17.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 13 | $9,546 | $1,061 | 11.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 16 | $3,228 | $419.38 | 13.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 15 | $244.95 | $12.16 | 5.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 242 | 302 | $56,933 | $14,350 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 219 | 219 | $63,736 | $12,558 | 19.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 248 | 312 | $94,733 | $9,532 | 10.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 181 | 189 | $54,211 | $9,382 | 17.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 130 | 143 | $48,846 | $9,123 | 18.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 15 | 19 | $8,840 | $5,482 | 62.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 121 | 138 | $20,359 | $4,143 | 20.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 170 | 784 | $57,922 | $2,969 | 5.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 69 | 69 | $15,419 | $2,475 | 16.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 62 | 81 | $12,532 | $2,415 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 29 | $7,923 | $1,997 | 25.2% |
About Mona Olive, FNP
Mona Olive, FNP is a Family healthcare provider based in Athens, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235687807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mona Olive, FNP has received a total of $9,229 in payments from pharmaceutical and medical device companies, with $5,063 received in 2024. These payments were reported across 380 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,592).
As a Medicare-enrolled provider, Olive has provided services to 4,191 Medicare beneficiaries, totaling 6,391 services with total Medicare billing of $209,691. Data is available for 3 years (2021–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Athens, AL
- Active Since 09/13/2016
- Last Updated 02/23/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1235687807
Products in Payments
- Sotyktu (Drug) $1,439
- TREMFYA (Drug) $1,100
- RINVOQ (Biological) $965.71
- VTAMA (Drug) $889.97
- SKYRIZI (Biological) $768.18
- DUPIXENT (Biological) $650.24
- ADBRY (Biological) $415.15
- Otezla (Drug) $298.29
- NUZYRA (Drug) $215.45
- Zoryve (Drug) $201.65
- Bimzelx (Biological) $194.09
- JUBLIA (Drug) $160.27
- OPZELURA (Drug) $159.39
- ACTHAR (Biological) $134.27
- ILUMYA (Biological) $129.89
- SILIQ (Drug) $123.10
- COSENTYX (Drug) $82.27
- TALTZ (Drug) $77.76
- Winlevi (Drug) $64.53
- EUCRISA (Drug) $59.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Athens
Amanda Pack, Np, NP
Family — Payments: $13,342
Family $13,342
Katelyn Gillespie, Np, NP
Family — Payments: $10,429
Family $10,429
Mary Mongare, Fnp-C, FNP-C
Family — Payments: $8,110
Family $8,110
Christen Mccabe, Fnp, FNP
Family — Payments: $7,587
Family $7,587
Mrs. Amanda Stephens, Np, NP
Family — Payments: $6,720
Family $6,720
Mrs. Jamie Williams, Msn, Np-C, MSN, NP-C
Family — Payments: $6,025
Family $6,025